Apogepha
| APOGEPHA
|
|
|---|---|
 |
|
| legal form | Company with limited liability |
| founding | 1882 |
| Seat | Dresden , Germany |
| management | Markus Bauer (since 2011) |
| Number of employees | 146 (as of 2019) /> |
| sales | 36 million euros |
| Branch | Pharmaceutical manufacturer |
| Website | www.apogepha.de |
| Status: 2015 | |
.jpg)
The APOGEPHA Arzneimittel GmbH (short APOGEPHA ) is the pharmacist in C. Stephan 1882 Dresden founded by German pharmaceutical company .
The name stands for Apo Theker Ge cooperative for pha rmazeutische preparations. As an international family company, Apogepha has specialized in the development and manufacture of urological medicines .
history
The company was founded in 1882 by the owners of the Dresdner Kronenapotheke Carl Stephan and Dr. Ostermeyer founded as C. Stephan - Factory of pharmaceutical preparations . Various chemical and pharmaceutical preparations were manufactured, but also veterinary drugs and cosmetic products. After several changes of ownership, the company headquarters was relocated to the Striesen district in 1919 (Kyffhäuserstraße 27) and converted into a stock corporation. The supervisory board chairman was temporarily Ottomar von Mayenburg , inventor of the toothpaste Chlorodont . In 1927 Mayenburg incorporated the company into its Leo works, but sold it to the Saxon Pharmacists' Cooperative just four years later.
Economic reasons led to the takeover of Apogepha GmbH in 1933 by the previous technical manager, the chemist and pharmacist Johannes Starke together with the Leipzig businessman Max Biering. The share capital at that time was 60,000 Reichsmarks.
After the Second World War and the almost complete destruction of the company during the air raid on Dresden in 1945, the company's boss Johannes Starke introduced chemical synthesis in the company and thus ensured successful economic development. In 1961, in response to political pressure, state participation had to be taken up. In 1972 the company was expropriated and transformed into a VEB . Christian Starke, who took over the business after the death of his father in 1968, was still in charge of VEB Apogepha for a short time until he finally handed over the management and took over the management of the research department.
In 1974, several other pharmaceutical companies from Dresden, which had also been expropriated in the wave of nationalization in 1972, were merged into VEB Apogepha. From 1983 the company was part of the VEB Sächsisches Serumwerk . In 1991 Christian Starke succeeded in reprivatising the company as the first pharmaceutical company in the new federal states. Since then it has been owned by the Starke family again. In 1996 new production facilities were built in Dresden- Lockwitz , which were closed at the end of 2018.
Medical research and development
The company invests around 10 percent of annual sales in research and development. The company's most important in-house development is propiverine , an active ingredient for the treatment of urinary incontinence and bladder weakness. It was developed in the 1980s. Apogepha offers prescription drugs as well as self-medication drugs for numerous urological uses such as bladder weakness , bladder cancer , prostate cancer , etc.
literature
- Steffi Liebig: Apogepha - The story of a Dresden pharmaceutical company . In: Dirk Schultheiss, Friedrich Moll: The history of urology in Dresden . 2009, ISBN 3-642-03593-0 , page 140 ff. ( Limited preview in the Google book search).
- Dietrich Buschbeck: Change of staff at APOGEPHA in Blasewitz-Striesen , in Elbhang-Kurier, issue 12/2001.
- Annette Binninger: "An irrational driving force" - Dresdner Apogepha-Arzneimittel GmbH is celebrating its 120th anniversary this year , in: Dresdner Latest News, June 2002
- Brigitte Düring and Michael Schäfer: Apogepha Arzneimittel - a company history. With a contribution by Christian Starke. Edition Leipzig. Leipzig 2016.
Web links
Individual evidence
- ↑ Data and facts. Apogepha, accessed January 20, 2017 .
- ↑ Tobias Lau: Apogepha: Off for the Dresden plant . In: Apotheke Adhoc, April 10, 2018, accessed on June 5, 2020.